Faris Alaa Sultan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Faris Alaa Sultan has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Muhanad Alzahrani
Department of Medicine, University of Maryland Medical Center, Baltimore, USA
10 shared publications - Abdullah Alabbasi
Ministry of Health, Jeddah, Saudi Arabia
7 shared publications - Hatan Mortada
Division of Plastic Surgery, Department of Surgery, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia
3 shared publications Ziyad Alzahrani
3 shared publications- Abdullah Alabbasi
Division of Family Medicine, Department of Jeddah First Cluster, Joint Program of Family Medicine, Jeddah, Saudi Arabia
2 shared publications Alaa A. Sultan
Division of Plastic Surgery, Department of Surgery, Faculty of Medicine, Umm Al-Qura University, Makkah, Saudi Arabia
2 shared publications
Latest Publications
- Open Access
- 2 November 2026
- Published by Springer Nature in BMC Cancer
Pretreatment systemic inflammatory ratios and survival in osteosarcoma and other primary bone sarcomas: a systematic review and meta-analysis
Background: Evidence for neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) in primary bone sarcoma is dominated by osteosarcoma and has been affected by inconsistent endpoint and effect-size extraction. We re-extracted eligible estimates from the primary reports and evaluated their independent prognostic associations. Methods: MEDLINE, Embase, Web of Science, Scopus, and Cochrane CENTRAL were searched for cohort studies reporting pretreatment NLR, PLR, or LMR in primary bone sarcoma. The primary analysis required clinically multivariable-adjusted, categorical high-versus-low hazard ratios (HRs). Overall survival (OS) was analyzed separately from progression-free survival (PFS), disease-free survival (DFS), event-free survival (EFS), and disease-specific mortality. Random-effects models used restricted maximum likelihood (REML) estimation and Hartung-Knapp confidence intervals. Histology- and Newcastle-Ottawa Scale (NOS)-based subgroup analyses were prespecified when at least two studies were available. Results: Ten studies remained in the systematic review, and nine contributed at least one source-verifiable endpoint-specific adjusted estimate to quantitative synthesis. Seven NLR-OS cohorts yielded a pooled HR of 1.64 (95% CI 1.15–2.33; I² = 81.4%). The osteosarcoma-only subgroup remained significant (five cohorts; HR 1.70, 95% CI 1.03–2.81; I² = 86.6%). Excluding Huang X 2019 from the strict dataset yielded HR 1.84 (95% CI 1.44–2.36; I² = 0%); the reviewer-specified comparison against the previous eight-estimate set, retaining Yang Q 2020 only as a source-reported sensitivity input, yielded HR 1.90 (95% CI 1.47–2.45; I² = 5.9%). PLR was not associated with OS (four cohorts; HR 1.07, 95% CI 0.67–1.72; I² = 56.0%). LMR showed a non-significant protective trend (three cohorts; HR 0.70, 95% CI 0.38–1.27; I² = 0%). Conclusions: Higher pretreatment NLR is associated with poorer OS, including in the strict osteosarcoma-only analysis. The direction remained stable in every leave-one-out analysis, while the marked reduction in heterogeneity after excluding Huang X 2019 identifies one dominant statistical influence. Retrospective designs and residual heterogeneity limit clinical application. PLR and LMR findings remain inconclusive, and whether NLR-guided management improves outcomes is untested.
- 2 November 2026
- Published by Springer Nature in BMC Cancer
Open AccessPretreatment systemic inflammatory ratios and survival in osteosarcoma and other primary bone sarcomas: a systematic review and meta-analysis
Background: Evidence for neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) in primary bone sarcoma is dominated by osteosarcoma and has been affected by inconsistent endpoint and effect-size extraction. We re-extracted eligible estimates from the primary reports and evaluated their independent prognostic associations. Methods: MEDLINE, Embase, Web of Science, Scopus, and Cochrane CENTRAL were searched for cohort studies reporting pretreatment NLR, PLR, or LMR in primary bone sarcoma. The primary analysis required clinically multivariable-adjusted, categorical high-versus-low hazard ratios (HRs). Overall survival (OS) was analyzed separately from progression-free survival (PFS), disease-free survival (DFS), event-free survival (EFS), and disease-specific mortality. Random-effects models used restricted maximum likelihood (REML) estimation and Hartung-Knapp confidence intervals. Histology- and Newcastle-Ottawa Scale (NOS)-based subgroup analyses were prespecified when at least two studies were available. Results: Ten studies remained in the systematic review, and nine contributed at least one source-verifiable endpoint-specific adjusted estimate to quantitative synthesis. Seven NLR-OS cohorts yielded a pooled HR of 1.64 (95% CI 1.15–2.33; I² = 81.4%). The osteosarcoma-only subgroup remained significant (five cohorts; HR 1.70, 95% CI 1.03–2.81; I² = 86.6%). Excluding Huang X 2019 from the strict dataset yielded HR 1.84 (95% CI 1.44–2.36; I² = 0%); the reviewer-specified comparison against the previous eight-estimate set, retaining Yang Q 2020 only as a source-reported sensitivity input, yielded HR 1.90 (95% CI 1.47–2.45; I² = 5.9%). PLR was not associated with OS (four cohorts; HR 1.07, 95% CI 0.67–1.72; I² = 56.0%). LMR showed a non-significant protective trend (three cohorts; HR 0.70, 95% CI 0.38–1.27; I² = 0%). Conclusions: Higher pretreatment NLR is associated with poorer OS, including in the strict osteosarcoma-only analysis. The direction remained stable in every leave-one-out analysis, while the marked reduction in heterogeneity after excluding Huang X 2019 identifies one dominant statistical influence. Retrospective designs and residual heterogeneity limit clinical application. PLR and LMR findings remain inconclusive, and whether NLR-guided management improves outcomes is untested.
- 28 September 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- p. 1-14
Efficiency of Tranexamic Acid for Prevention of Bleeding In Breast Surgery: A Systematic Review
- 28 September 2026
- Published by Springer Nature in Aesthetic Plastic Surgery
- p. 1-14
Efficiency of Tranexamic Acid for Prevention of Bleeding In Breast Surgery: A Systematic Review
- Open Access
- 1 July 2026
- Published by KEAI Publishing in Advances in Biomarker Sciences and Technology
- Vol. 9 (1) , 83-92
Molecular Diagnostics and Targeted Therapeutic Strategies in Epithelioid Sarcoma: A Scoping Review
- 1 July 2026
- Published by KEAI Publishing in Advances in Biomarker Sciences and Technology
- Vol. 9 (1) , 83-92
Open AccessMolecular Diagnostics and Targeted Therapeutic Strategies in Epithelioid Sarcoma: A Scoping Review
- Open Access
- 7 April 2026
- Published by Springer Nature in Patient Safety in Surgery
- Vol. 20 (1) , 10
Severe rapidly progressing multi‑resistant polymicrobial surgical site infection after elective abdominoplasty: a case report
Adverse events following elective cosmetic surgery can raise concerns about patient safety, particularly in facilities with variable oversight of infection
- 7 April 2026
- Published by Springer Nature in Patient Safety in Surgery
- Vol. 20 (1) , 10
Open AccessSevere rapidly progressing multi‑resistant polymicrobial surgical site infection after elective abdominoplasty: a case report
Adverse events following elective cosmetic surgery can raise concerns about patient safety, particularly in facilities with variable oversight of infection
- 7 March 2026
- Published by SAGE Publications in American Journal of Hospice and Palliative Medicine®
Safety and Feasibility of Hypodermoclysis in Advanced Cancer: A Systematic Review and Meta-Analysis
Background: Clinically assisted hydration in advanced cancer remains controversial, with uncertainty regarding potential benefits and harms near the end of life. Hypodermoclysis offers a less invasive alternative to intravenous hydration, yet safety outcomes have not been clearly quantified. Methods: We conducted a systematic review and meta-analysis following PRISMA 2020 guidelines to evaluate the safety and feasibility of hypodermoclysis in adults with advanced cancer receiving palliative or hospice care. Randomized and observational studies reporting outcomes related to subcutaneous fluid administration were included. Local infusion-site complications and treatment discontinuation were pooled using random-effects meta-analysis when data were comparable. Results: Five studies met inclusion criteria, including cohort studies and randomized trials conducted in palliative settings, with 3 studies suitable for quantitative synthesis. Pooled analysis estimated that approximately 17% of patients experienced local infusion-site complications, although events were predominantly mild and rarely required treatment discontinuation. Randomized trials did not consistently demonstrate improvements in symptoms or survival associated with clinically assisted hydration. Conclusions: Hypodermoclysis appears to be a feasible and generally safe hydration method in advanced cancer care, with complications typically minor. However, evidence supporting routine hydration remains limited, and decisions should be individualized according to patient goals and symptom burden.
- 7 March 2026
- Published by SAGE Publications in American Journal of Hospice and Palliative Medicine®
Safety and Feasibility of Hypodermoclysis in Advanced Cancer: A Systematic Review and Meta-Analysis
Background: Clinically assisted hydration in advanced cancer remains controversial, with uncertainty regarding potential benefits and harms near the end of life. Hypodermoclysis offers a less invasive alternative to intravenous hydration, yet safety outcomes have not been clearly quantified. Methods: We conducted a systematic review and meta-analysis following PRISMA 2020 guidelines to evaluate the safety and feasibility of hypodermoclysis in adults with advanced cancer receiving palliative or hospice care. Randomized and observational studies reporting outcomes related to subcutaneous fluid administration were included. Local infusion-site complications and treatment discontinuation were pooled using random-effects meta-analysis when data were comparable. Results: Five studies met inclusion criteria, including cohort studies and randomized trials conducted in palliative settings, with 3 studies suitable for quantitative synthesis. Pooled analysis estimated that approximately 17% of patients experienced local infusion-site complications, although events were predominantly mild and rarely required treatment discontinuation. Randomized trials did not consistently demonstrate improvements in symptoms or survival associated with clinically assisted hydration. Conclusions: Hypodermoclysis appears to be a feasible and generally safe hydration method in advanced cancer care, with complications typically minor. However, evidence supporting routine hydration remains limited, and decisions should be individualized according to patient goals and symptom burden.
- Open Access
- 5 March 2026
- Published by Springer Nature in Discover Public Health
- Vol. 23 (1) , 286
The role of primary care in improving equity and access to cancer services in Saudi Arabia
This narrative review examines how primary care can improve equitable access to cancer services in Saudi Arabia, where cancer incidence continues to rise due to demographic transitions, lifestyle changes, and improved diagnostic detection. While secondary and tertiary oncology services have expanded nationally, primary care remains challenged in delivering consistent early cancer detection, equitable referral pathways, and guideline-based screening implementation. A structured literature search was conducted across MEDLINE, Embase, CINAHL, Google Scholar, and relevant grey literature, including Ministry of Health reports and national screening program documents. Evidence addressing physician practices, patient barriers, system-level inequities, diagnostic access, and referral processes was synthesized thematically. Findings indicate persistent underutilization of colorectal, breast, and prostate cancer screening, delays in presentation influenced by sociocultural factors, limited diagnostic capacity within primary health care centers, and regional disparities that particularly disadvantage rural populations. Evidence also suggests that inconsistent referral processes and variability in physician training contribute to inequitable cancer service access. Strengthening evidence-based screening implementation, embedding decision support tools within electronic health records, enhancing oncology training for primary care physicians, standardizing referral pathways, and implementing culturally sensitive community outreach strategies may improve early detection and equity in service delivery. Aligning these efforts with Vision 2030 health reforms offers an opportunity to reinforce a primary care–centered model of cancer prevention and early detection across the Kingdom.
- 5 March 2026
- Published by Springer Nature in Discover Public Health
- Vol. 23 (1) , 286
Open AccessThe role of primary care in improving equity and access to cancer services in Saudi Arabia
This narrative review examines how primary care can improve equitable access to cancer services in Saudi Arabia, where cancer incidence continues to rise due to demographic transitions, lifestyle changes, and improved diagnostic detection. While secondary and tertiary oncology services have expanded nationally, primary care remains challenged in delivering consistent early cancer detection, equitable referral pathways, and guideline-based screening implementation. A structured literature search was conducted across MEDLINE, Embase, CINAHL, Google Scholar, and relevant grey literature, including Ministry of Health reports and national screening program documents. Evidence addressing physician practices, patient barriers, system-level inequities, diagnostic access, and referral processes was synthesized thematically. Findings indicate persistent underutilization of colorectal, breast, and prostate cancer screening, delays in presentation influenced by sociocultural factors, limited diagnostic capacity within primary health care centers, and regional disparities that particularly disadvantage rural populations. Evidence also suggests that inconsistent referral processes and variability in physician training contribute to inequitable cancer service access. Strengthening evidence-based screening implementation, embedding decision support tools within electronic health records, enhancing oncology training for primary care physicians, standardizing referral pathways, and implementing culturally sensitive community outreach strategies may improve early detection and equity in service delivery. Aligning these efforts with Vision 2030 health reforms offers an opportunity to reinforce a primary care–centered model of cancer prevention and early detection across the Kingdom.
- Open Access
- 28 February 2026
- Published by Institute of Lifestyle Medicine in Journal of Lifestyle Medicine
- Vol. 16 (1) , 32-38
Accelerated Muscle Strength Decline and Reduced Lean Mass in Adults with Treated Inflammatory Bowel Disease: A NHANES Study
Muhanad Alzahrani, Abdullah Alabbasi, Mohammed Sayes, Rayyan Fahad Hamoud Altemani, Ziyad Alzahrani, Faris Sultan. JLM 2026;16:32-8. https://doi.org/10.15280/jlm.2026.16.1.32
- 28 February 2026
- Published by Institute of Lifestyle Medicine in Journal of Lifestyle Medicine
- Vol. 16 (1) , 32-38
Open AccessAccelerated Muscle Strength Decline and Reduced Lean Mass in Adults with Treated Inflammatory Bowel Disease: A NHANES Study
Muhanad Alzahrani, Abdullah Alabbasi, Mohammed Sayes, Rayyan Fahad Hamoud Altemani, Ziyad Alzahrani, Faris Sultan. JLM 2026;16:32-8. https://doi.org/10.15280/jlm.2026.16.1.32
- Open Access
- 31 January 2026
- Published by Elsevier in JPRAS Open
- Vol. 49, 71-77
Conservative tissue sparing management of pediatric pyogenic granuloma with preserved joint function: A narrative review with an illustrative case
- 31 January 2026
- Published by Elsevier in JPRAS Open
- Vol. 49, 71-77
Open AccessConservative tissue sparing management of pediatric pyogenic granuloma with preserved joint function: A narrative review with an illustrative case
- Open Access
- 1 January 2026
- Published by KEAI Publishing in Chinese Journal of Plastic and Reconstructive Surgery
Beneath the surface: Incidental discovery of a large uterine fibroid during abdominoplasty
- 1 January 2026
- Published by KEAI Publishing in Chinese Journal of Plastic and Reconstructive Surgery
Open AccessBeneath the surface: Incidental discovery of a large uterine fibroid during abdominoplasty